...
首页> 外文期刊>Hematology/Oncology and Stem Cell Therapy >Case Report Acquired amegakaryocytic thrombocytopenia and red cell aplasia in a patient with thymoma progressing to aplastic anemia successfully treated with allogenic stem cell transplantation
【24h】

Case Report Acquired amegakaryocytic thrombocytopenia and red cell aplasia in a patient with thymoma progressing to aplastic anemia successfully treated with allogenic stem cell transplantation

机译:病例报告成功进行异基因干细胞移植治疗的胸腺瘤进展为再生障碍性贫血的患者获得了巨核细胞血小板减少和红细胞发育不全

获取原文

摘要

Association of pure red-cell aplasia with thymoma is well documented. However, acquired amegakaryocytic thrombocytopenia (AAMT) has been rarely associated with thymoma with only five reported cases in literature. We report a patient with thymoma complicated by pure red cell aplasia (PRCA) and AAMT who progressed to develop aplastic anemia (AA). The patient was refractory to 10-months of immunosuppressive therapy with cyclosporine, prednisone, and antithymocyte globulin. She was eventually treated with allogeneic stem cell transplantation (allo-SCT). On Day +323 the patient continues to be transfusion-independent. This case illustrates how in patients with thymoma and AAMT may herald development of AA. This is also the first report of a patient with AAMT progressing to thymoma-associated AA being successfully treated with allo-SCT. The successful outcome suggests allo-SCT as a feasible option similar to other AA patients.
机译:纯红细胞发育不全与胸腺瘤的关联已有充分文献记载。然而,获得性巨核细胞减少血小板减少症(AAMT)很少与胸腺瘤相关,文献中仅报道了五例。我们报告一名胸腺瘤并发纯红细胞发育不全(PRCA)和AAMT的患者,进展为再生障碍性贫血(AA)。该患者使用环孢素,泼尼松和抗胸腺细胞球蛋白的免疫抑制治疗不能耐受10个月。最终她接受了异体干细胞移植(allo-SCT)治疗。在第+323天,患者继续独立于输血。该病例说明了胸腺瘤和AAMT患者可能预示着AA的发展。这也是AloMT病人成功发展为与胸腺瘤相关的AA的异体SCT治疗的首例报道。成功的结果表明,与其他AA患者相似,allo-SCT是可行的选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号